搜索结果: 1-15 共查到“医学 pancreatic”相关记录41条 . 查询时间(0.718 秒)
2017胰腺疾病戈登学术会议(The 2017 Gordon Research Conference on Pancreatic Diseases)
Pancreatic Diseases pancreatic development
2017/1/14
Despite the rapid advances in our understanding of the molecular mechanisms involved in pancreatic development, regeneration, and malignant transformation, as well as our ability to model these proces...
上海交通大学医学院医学影像学英文课件 Hepatobiliary Pancreatic Radiology
上海交通大学医学院 医学影像学 英文 课件 Hepatobiliary Pancreatic Radiology
2016/12/29
上海交通大学医学院医学影像学英文课件 Hepatobiliary Pancreatic Radiology.
Two original research communications and 2 editorials in this
month’s issue of the Journal illustrate the dilemmas of the current
treatment of obesity (1–4). The paper by Astrup et al (1) and
edito...
Integrated psychosocial and supportive care needed for patients with pancreatic cancer
Pancreatic cancer disease cancer morbidity and mortality
2017/2/22
Pancreatic cancer is acknowledged as one of the most challenging diseases in the 21st century. Despite the recent focus on research and novel therapies, by 2030 pancreatic cancer is projected to be th...
Palliative care in advanced pancreatic cancer
Patients with advanced pancreatic cancer treatment pancreatic cancer pathophysiology
2017/2/22
The management of patients with advanced pancreatic cancer often requires a multi-disciplinary approach with individualised therapy. Addressing the underlying causes of several of the troublesome symp...
The changing landscape of systemic therapy in advanced pancreatic cancer
Pancreatic cancer disease congenital resistant to treatment
2017/2/22
Pancreatic cancer is a highly lethal disease due to its late presentation and its innate resistance to treatment. Although much research has been conducted in order to discover and develop new therape...
Radiotherapy in locally advanced pancreatic cancer
Radiation therapy the treatment mode advanced pancreatic cancer radiation therapy
2017/2/22
While radiotherapy was considered an important treatment modality in locally advanced pancreatic cancer for several decades, the presentation of the LAP 07 trial results have impressed a concept that ...
The role of radiotherapy in pancreatic cancer is controversial. Its utility in treatment has been investigated in a number of clinical settings, including before and after surgery for operable cancers...
Pancreatic neuroendocrine tumours–a rare pancreatic tumour
David L Chan Nick Pavlakis Paul Roach Dale Bailey Jennifer Arena Eva Segelov
2017/2/22
Pancreatic neuroendocrine tumours are rare tumours that can either present with syndromes from excess hormonal production or from mass effect – from the primary or metastases. They vary widely in clin...
Inherited pancreatic cancer
Pancreatic cancer genetic tumor susceptibility syndrome genetic pancreatic cancer
2017/2/22
Up to 10% of pancreatic cancer cases have a heritable component. Some of these are clearly defined tumour predisposition syndromes known as hereditary pancreatic cancers, but most are familial cases, ...
Novel therapeutics and preclinical imaging for pancreatic cancer – view from the lab
Pancreatic cancer damaging disease tumor microenvironment fibrosis and cancer cells
2017/2/22
Pancreatic cancer is a devastating disease with a five-year survival rate of 6%. A key driver of disease progression is the tumour microenvironment, which is characterised by fibrosis. A dynamic inter...
Role of the microenvironment in chronic pancreatitis and pancreatic cancer
Chronic pancreatitis exocrine pancreas inflammatory bowel disease pancreatic ductal adenocarcinoma enzyme acini pancreatic stellate cell activation
2017/2/22
Chronic pancreatitis, an inflammatory disease of the exocrine pancreas, has been reported to be a major risk factor for the development of pancreatic ductal adenocarcinoma. Evidence from pre-clinical ...
Genomics of pancreatic tumours-what we now know
Pancreatic cancer tumor complex landscape pancreatic cancer genome
2017/2/22
Each year, over 2500 patients in Australia are diagnosed with pancreatic cancer. Pancreatic cancer is one of the most lethal tumour types with a five year survival of just 5%, thus there is a need to ...